Kind en Transfusie
LiteratuurOp deze pagina vindt u literatuur rond het thema Kind en Transfusie, geordend op topic.
Bloedproducten
PAS-E trombocyten in kinderen vermindert aantal allergische reacties
Cohn CS, Stubbs J, Schwartz J, Francis R, Goss C, Cushing M, Shaz B, Mair D, Brantigan B, Heaton WA.; A comparison of adverse reaction rates for PAS C versus plasma platelet units. Transfusion 2014;54:1927-34
Hirayama J, Azuma H, Fujihara M, Homma C, Yamamoto S, Ikeda H.: Storage of platelets in a novel additive solution (M-sol), which is prepared by mixing solutions approved for clinical use that are not especially for platelet storage. Transfusion 2007;47:960-5
Honohan A, van ’t Ende E, Hulzenbos C, Lopriore E, van ’t Verlaat E, Govaart P, Brand A, van der Bom J.: Post-transfusion platelet increments after different platelet products in neonates: a retrospective cohort study. Transfusion 2-13;53:3100-9
Hout, van FMA, van der Meer PF, Wiersum-Osselton JC, Middelburg RA, Schipperus MR, van der Bom JG, Kerkhoffs JL.: Transfusion reactions after transfusion of platelets stored in PAS-B, PAS-C, or plasma: a nationwide comparison. Transfusion. 2018 Apr;58(4):1021-1027
Ignatova AA, Karpova OV, Trakhtman PE, Rumiantsev SA, Panteleev MA.: Functional characteristics and clinical effectiveness of platelet concentrates treated with riboflavin and ultraviolet light in plasma and in platelet additive solution. Vox Sang 2016;110:244-52
Yanagisawa R, Shimodaira S, Kojima S, Nakasone N (et al). Koike K.; Replaced platelet concentrates containing a new additive solution, M-sol: safety and efficacy for pediatric patients. Transfusion 2013;53:2053-60
Omniplasma gebruik in kinderen en neonaten vertoont een goed safety profiel
Camazine M.N., Karam O., Colvin R, LEteurte S., Demaret P., Tucci M., Muszynski J.A., Stanworth S., Spinella P.C.: Outcomes related to the use of frozen plasma or pooled solvent/detergent treated plasma in critically ill children. Pediatr Crit Care Med 2017;18:e215-223
Chekrizova V., Murphy W.G.: Solvent-detergent plasma: use in neonatal patients, in adult and paediatric patients with liver disease and in obstetric and gynaecological emergencies. Transf Med 2006;16:85-91
Patient blood management
Massaal bloedverlies bij kinderen met trauma: niet alleen rode-bloedceltransfusies geven, maar nog controverse t.a.v. precieze transfusiebeleid
Hwu R.S., Spinella P.C., Keller M.S., Baker D., Wallendorf M., Leonard J.C.: The effect of massive transfusion protocol implementation on pediatric trauma care. Transfusion 2016;56:2712-2719
Shaz B.H., Dente C.J., Nicholas J., MacLeod J.B. et al: Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion 2010;50:493-500
Butler E.K., Mills B.M., Arbabi S., Bulger E.M., Vavilala M.S. et al: Association of blood component ratios with 240 hour mortality in injured children receiving massive transfusion. Crit Care Med 2019;47:975-983
Makyszek R.W., Leraas H.J., Reed C., Ray C.M., Nag U.P., Poisson J.L., Tracy E.T.: Massive transfusion in the pediatric population: a systematic review and summary of best-evidence practice strategies. J. Trauma Acute Care Surg 2019;86:744-754
Transfusies in cardio-thoraxchirurgie bij kinderen
Delaney M., Stark P.C., Suh M., Triulzi D.J., Hess J.R. et al: Massive transfusion in cardiac surgery: the impact of blood component ratios on clinical outcomes and survival. Anesth Analg 207;124:1777-1782v
Minder bloedplaatjestransfusies en meer aandacht voor bloedsparende technieken bij prematuren is belangrijk, maar controverse blijft voor rode-bloedceltransfusies
Curley A., Stanworth S.J., Willoughny K., Fustolo-Gunnink S.F. et al: Randomized trial pf platelet-transfusion thresholds in neonates. N. Eng. J. Med 2019;380:242-251
Lopriore E.: Updates in red blood cell and platelet transfusions in preterm neonates. Am J Perinatol 2019;36:S37-S40
Ohlsson A., Aher S.M.: Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev.2006;3:CD004863
Aher S., Ohlsson A.: Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst. Rev. 2006;3:CD004868
Bell E.F., Strauss R.G, Widness J.A., Mahoney L.T. et al: Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics 2005;115:1685-91
Restrictief rode-bloedceltransfusie beleid bij kinderen op een IC mogelijk beter
Parker I: Transfusion in critically ill children: indications, risks and challenges. Critical care medicine 2014;42:675-690
Kinderen met een hemato-oncologische aandoening ontvangen veel transfusies, bloeden meer bij jongere leeftijd
Bercovitz R.S., Josephson C.D.: Transfusion considerations in pediatric hematology and oncology patients. Hematol Oncol CLin North Am 2016;30:695-709
Josephson C.D., Granger S., Assmann S.F., Castillejo M.I. et al: Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia. Blood 2012;120:748-60
Granulocytentranfusies is mogelijk gunstig in een sub-groep van kinderen, data alleen observationeel verkregen
Estcourt L.J., Stanworth S., Doree C., Blanco P., Hopewell S., Trivella M., Massey E.: Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev 2015;6;CD005341
Gurlek Gokcebay D.,Akpinar Tekgunduz S.: Granulocyte transfusions in the management of neutropenic fever: A pediatric perspective. Transf Apher Sci 2018;57:16-19
Díaz R., Soundar E., Hartman S.K., Dreyer Z., Teruya J., Hui S.K.: Granulocyte transfusions for children with infection and neutropenia or granulocyte dysfunction. Pediatr Hematol Oncol 2014;31:425-34
Service en ondersteuning
